Vasohibin as an endothelium-derived negative feedback regulator of angiogenesisKazuhide Watanabe, Yasufumi Sato|Journal of Clinical Investigation|2004Cited by 287
Vasohibin as an endothelium-derived negative feedback regulator of angiogenesisKazuhide Watanabe, Yasufumi Sato|Journal of Clinical Investigation|2004Cited by 263
Vasohibin‐2 is required for epithelial–mesenchymal transition of ovarian cancer cells by modulating transforming growth factor‐β signalingRie Iida‐Norita, Yasufumi Sato|Cancer Science|2017Cited by 34
Expression of vasohibin-2 in pancreatic ductal adenocarcinoma promotes tumor progression and is associated with a poor clinical outcome.Jung Chul Kim, Hyung-Seok Kim, Yasufumi Sato et al.|PubMed|2015Cited by 20
Enhanced humoral immunity in breast cancer patients with high serum concentration of anti‐HER2 autoantibodyYasufumi Sato, Kenzo Shimazu|Cancer Medicine|2021Cited by 13